#1 Clinical Trials Search in Europe

Suxamethonium Chloride

This article examines the use of Suxamethonium Chloride, also known as succinylcholine, in various clinical trials. Suxamethonium Chloride is a muscle relaxant commonly used in anesthesia and emergency medical procedures. The trials discussed here investigate its effectiveness, safety, and comparison to other neuromuscular blocking agents in different medical contexts, including electroconvulsive therapy, intubation, and surgical procedures.

Table of Contents

What is Suxamethonium Chloride?

Suxamethonium chloride, also known as succinylcholine or by brand names like Anectine, Quelicin, or Suxamethonium Aguettant, is a medication used to cause short-term muscle relaxation[1][2]. It belongs to a class of drugs called neuromuscular blocking agents, which work by temporarily paralyzing the muscles[3].

Medical Uses

Suxamethonium chloride is primarily used in medical procedures where muscle relaxation is needed for a short period. Some common uses include:

  • Intubation: It helps relax the muscles of the throat to allow easier insertion of a breathing tube during general anesthesia[1].
  • Electroconvulsive Therapy (ECT): It’s used to relax muscles during ECT treatments for severe depression[4].
  • Short Surgical Procedures: It can provide muscle relaxation for brief operations[5].
  • Emergency Situations: It’s sometimes used in emergency intubations, such as in cases of respiratory distress or major trauma[1].

How Suxamethonium Chloride Works

Suxamethonium chloride works by blocking the communication between nerves and muscles. This causes a temporary paralysis of the muscles, including those used for breathing. The effect is rapid, typically occurring within 30-60 seconds after administration, and usually lasts for about 5-10 minutes[5].

How It’s Administered

Suxamethonium chloride is given as an injection into a vein (intravenously) by a healthcare professional. The dose is typically calculated based on the patient’s weight. For example:

  • For intubation: A dose of 1 mg per kilogram of body weight is common[1].
  • For ECT: A dose of 1 mg per kilogram is also typically used[4].
  • For short surgical procedures: A dose of 1 mg per kilogram, followed by continuous infusion if needed[5].

Comparison to Other Muscle Relaxants

Suxamethonium chloride is often compared to other muscle relaxants, particularly rocuronium. Here are some key differences:

  • Speed of Action: Suxamethonium typically works faster than rocuronium[1].
  • Duration of Effect: Suxamethonium’s effects wear off more quickly than rocuronium’s[5].
  • Reversibility: The effects of rocuronium can be quickly reversed with a drug called sugammadex, while suxamethonium’s effects must wear off naturally[4].

Potential Side Effects

While suxamethonium chloride is generally safe when used appropriately, it can have some side effects. These may include:

  • Muscle Pain: Some patients experience muscle soreness after the medication wears off[1].
  • Changes in Heart Rate: It can cause temporary changes in heart rhythm[1].
  • Increased Potassium Levels: In some cases, it can cause a temporary increase in blood potassium levels[5].
  • Allergic Reactions: As with any medication, some people may have an allergic reaction[3].

Ongoing Research

Researchers continue to study suxamethonium chloride to better understand its effects and compare it to other muscle relaxants. Some areas of current research include:

  • Comparing suxamethonium to rocuronium for rapid sequence intubation in emergency situations[1].
  • Investigating the use of suxamethonium in elderly patients undergoing ECT[3].
  • Studying the effects of small doses of suxamethonium in non-intubated thoracoscopic surgery[6].
  • Comparing the recovery time from suxamethonium to that of rocuronium reversed by sugammadex in ECT procedures[4].
Aspect Details
Primary Uses Rapid intubation, muscle relaxation for ECT, short surgical procedures
Comparisons Often compared to rocuronium and other neuromuscular blocking agents
Dosage Typically 1 mg/kg, but may vary depending on the procedure
Key Outcomes Measured Intubation success rates, quality of muscle relaxation, recovery time, plasma potassium changes, adverse events
Potential Side Effects Changes in plasma potassium, cardiac arrhythmia, muscle soreness, shorter time to desaturation
Specific Applications Electroconvulsive therapy, prehospital emergency intubation, rapid sequence induction
Safety Considerations Monitored for adverse events, compared to other agents for safety profiles

FAQ

  • What is Suxamethonium Chloride used for in clinical trials? Suxamethonium Chloride is used in clinical trials for various purposes, including facilitating rapid intubation in emergency settings, providing muscle relaxation during electroconvulsive therapy (ECT), and assisting in short surgical procedures. It is often compared to other neuromuscular blocking agents to assess its effectiveness and safety.
  • How does Suxamethonium Chloride compare to other muscle relaxants? Several trials compare Suxamethonium Chloride to other muscle relaxants like rocuronium. For example, one study compares the recovery time of neuromuscular blockade between rocuronium reversed by sugammadex and Suxamethonium Chloride in ECT procedures. Another trial compares Suxamethonium Chloride to rocuronium for prehospital emergency intubation.
  • What are the potential side effects of Suxamethonium Chloride? Potential side effects of Suxamethonium Chloride mentioned in the trials include changes in plasma potassium levels, cardiac arrhythmia, muscle soreness, and shorter time to desaturation. Some studies aim to document the safety and adverse event rates of Suxamethonium Chloride compared to other muscle relaxants.
  • How is Suxamethonium Chloride administered in these clinical trials? The administration of Suxamethonium Chloride varies depending on the trial and procedure. For example, in one study for ECT, it is administered at a dose of 1 mg/kg. In another trial for prehospital emergency intubation, it is given as an IV administration of 1 mg/kg.
  • What are some of the key outcomes measured in these Suxamethonium Chloride trials? Key outcomes measured in these trials include intubation success rates, quality of muscle relaxation, recovery time from neuromuscular blockade, changes in plasma potassium levels, and the incidence of adverse events. Some trials also assess the effectiveness of Suxamethonium Chloride in specific procedures like electroconvulsive therapy or rapid sequence intubation.

Ongoing Clinical Trials on Suxamethonium Chloride

  • Study on the Effect of Rocuronium Bromide, Sugammadex, and Suxamethonium Chloride for Adults with Respiratory Distress Requiring Emergency Tracheal Intubation

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Suxamethonium Chloride: Also known as succinylcholine, it is a neuromuscular blocking agent used to cause short-term paralysis, typically to aid in tracheal intubation or other short medical procedures.
  • Neuromuscular blockade: A state where nerve impulses are prevented from reaching muscles, resulting in temporary paralysis. This is often induced during medical procedures to facilitate intubation or surgery.
  • Electroconvulsive therapy (ECT): A psychiatric treatment where electric currents are passed through the brain to trigger a brief seizure, used to treat certain mental health conditions.
  • Intubation: The process of inserting a tube through the mouth and into the airway to help a patient breathe during surgery or in emergency situations.
  • Rocuronium: Another type of neuromuscular blocking agent often compared to Suxamethonium Chloride in clinical trials.
  • Sugammadex: A medication used to reverse the effects of certain neuromuscular blocking agents, particularly rocuronium.
  • Train-of-four (TOF): A method of measuring the degree of neuromuscular blockade by applying four electrical stimuli and measuring the muscle response.
  • Rapid sequence induction: A medical procedure used to quickly secure a patient's airway while minimizing the risk of aspiration.
  • Plasma potassium levels: The amount of potassium in the blood, which can be affected by the use of certain muscle relaxants.
  • Laryngoscopy: The examination of the larynx (voice box) using a laryngoscope, often performed during intubation procedures.

References

  1. https://clinicaltrials.gov/study/NCT02000674
  2. https://clinicaltrials.gov/study/NCT06709066
  3. https://clinicaltrials.gov/study/NCT04868409
  4. https://clinicaltrials.gov/study/NCT03532178
  5. https://clinicaltrials.gov/study/NCT00751179
  6. https://clinicaltrials.gov/study/NCT03469323